Lv2
146 积分 2025-03-18 加入
Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects
10天前
已完结
Autoencoders reveal polyunsaturated fatty acids (PUFA)-Related metabolic signature linked to cancer risk
10天前
已完结
DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT
19天前
已完结
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
20天前
已完结
Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
21天前
已完结
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
21天前
已完结
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
1个月前
已完结
Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study
1个月前
已完结
Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study
2个月前
已完结
Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study
2个月前
已完结
皖公网安备34019202002308
